IL17F and B-cell chronic lymphocytic leukemia: A modest increase in activation of the canonical pNFkBp105 pathway was observed in CLL B cells but not healthy donor B cells following IL-17F modulation (Fig. 5), the difference between the two donor populations being significant (p < 0.05) as measured by the two-sided Student’s t test.